We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$2.11B
AUM Growth
+$194M
Cap. Flow
+$818M
Cap. Flow %
38.75%
Top 10 Hldgs %
58.11%
Holding
879
New
298
Increased
119
Reduced
90
Closed
306

Sector Composition

Rank Sector Weight
1 Healthcare 15.03%
2 Consumer Discretionary 11.05%
3 Financials 5.53%
4 Technology 3.61%
5 Industrials 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WKHS icon
326
CALL
Workhorse Group
WKHS
$34.2M
$93K ﹤0.01%
143
-12
-8% -$363K
FTAAW
327
DELISTED
FTAC Athena Acquisition Corp. Warrant
FTAAW
$93K ﹤0.01%
+71,302
New +$87.3K
RDUS
328
DELISTED
Radius Health, Inc.
RDUS
$93K ﹤0.01%
7,500
+6,860
+1,072% +$98.9K
FOXA icon
329
CALL
Fox Class A
FOXA
$26.1B
$92K ﹤0.01%
+153,000
New +$5.63M
SWCH
330
PUT
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$91K ﹤0.01%
211,000
+50,000
+31% +$1.17M
RCOR
331
DELISTED
Renovacor, Inc.
RCOR
$91K ﹤0.01%
10,000
-128,896
-93% -$1.26M
UHGWW
332
DELISTED
United Homes Group Warrant
UHGWW
$90K ﹤0.01%
+143,231
New +$126K
FIVN icon
333
PUT
FIVE9
FIVN
$2.44B
$88K ﹤0.01%
+51,200
New +$9.34M
SPGI icon
334
PUT
S&P Global
SPGI
$120B
$88K ﹤0.01%
+10,000
New +$4.33M
SLCRW
335
DELISTED
Silver Crest Acquisition Corporation Warrant
SLCRW
$88K ﹤0.01%
+134,015
New +$95.6K
DRNA
336
PUT
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$88K ﹤0.01%
+12,500
New +$345K
EEM icon
337
CALL
iShares MSCI Emerging Markets ETF
EEM
$29.9B
$87K ﹤0.01%
38,900
-1,580,500
-98% -$82.3M
MCRB icon
338
Seres Therapeutics
MCRB
$47M
$87K ﹤0.01%
+625
New +$122K
SCVX.WS
339
DELISTED
SCVX Corp.
SCVX.WS
$87K ﹤0.01%
108,237
-83,853
-44% -$75.1K
CORT icon
340
PUT
Corcept Therapeutics
CORT
$12.1B
$86K ﹤0.01%
25,000
-43,700
-64% -$915K
ET icon
341
CALL
Energy Transfer Partners
ET
$71.6B
$86K ﹤0.01%
48,500
-22,700
-32% -$218K
ACAD icon
342
Acadia Pharmaceuticals
ACAD
$5.07B
$85K ﹤0.01%
+5,121
New +$98.7K
FINMW
343
DELISTED
Marlin Technology Corporation Warrant
FINMW
$85K ﹤0.01%
+105,777
New +$100K
CRU.WS
344
DELISTED
Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CRU.WS
$85K ﹤0.01%
100,723
+1,293
+1% +$1.31K
CTRA
345
CALL
DELISTED
Coterra Energy
CTRA
$82K ﹤0.01%
20,000
SDACW
346
DELISTED
Sustainable Development Acquisition I Corp. Warrant
SDACW
$81K ﹤0.01%
118,847
+48,847
+70% +$39.2K
GXIIW
347
DELISTED
GX Acquisition Corp. II Warrant
GXIIW
$80K ﹤0.01%
+154,494
New +$136K
KWAC.WS
348
DELISTED
Kingswood Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common
KWAC.WS
$78K ﹤0.01%
163,098
+38,172
+31% +$22.3K
ASZ.WS
349
DELISTED
Austerlitz Acquisition Corporation II Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
ASZ.WS
$77K ﹤0.01%
+73,488
New +$82.1K
HUGS.WS
350
DELISTED
USHG Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
HUGS.WS
$76K ﹤0.01%
88,762
+64,165
+261% +$62.1K

Similar funds

Cowen and Company's Q3 2021 Portfolio in Review

As of Q3 2021, Cowen and Company held 879 positions worth $2.11B, up 10% from $1.92B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Cowen and Company deployed $818M of net new capital in Q3 2021, opening 298 new positions and adding to 119 existing holdings. Its largest new stake was Macquarie Infrastructure Holdings, LLC: 1,190,000 shares worth $48.3M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Nice, an estimated $7.38M trimmed.

  • Cowen and Company's largest Q3 2021 buy was Macquarie Infrastructure Holdings, LLC: 1,190,000 shares worth $48.3M.
  • Cowen and Company added most to FTAI Aviation in Q3 2021, an estimated $42.9M increase.
  • Cowen and Company's biggest Q3 2021 reduction was Nice, cutting an estimated $7.38M.
  • Cowen and Company fully exited Foley Trasimene Acquisition Corp. in Q3 2021, selling an estimated $15.1M.
  • Cowen and Company's ten largest holdings make up 58% of its $2.11B portfolio in Q3 2021.
  • Cowen and Company opened 298 new positions and closed 306 in Q3 2021.
  • Cowen and Company's portfolio value rose 10% quarter-over-quarter to $2.11B.

Based on Cowen and Company's 13F filing for Q3 2021, filed 12 Nov 2021.